Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular Carcinoma

被引：0
作者：
Jorge Filmus
Mariana Capurro
机构：
[1] Sunnybrook & Women’s College Health Sciences Centre,Division of Molecular and Cell Biology
来源：
Molecular Diagnosis | 2004年 / 8卷 / 4期
关键词：
Focal Nodular Hyperplasia; Serological Marker; Biliary Tract Cancer; Dysplastic Nodule; Benign Liver Disease;
D O I：
10.1007/BF03260065
中图分类号：
学科分类号：
摘要：
Hepatocellular carcinoma (HCC) is one of the most common types of malignant tumor. It is usually asymptomatic in the early stages and tends to be intravascularly and intrabiliary invasive. Therefore, most patients present with incurable disease at the time of detection and early diagnosis of HCC is critical for a good prognosis.
引用
收藏
页码：207 / 212
页数：5
相关论文
共 155 条
[1]  
Parkin DM(1999)Global cancer statistics CA Cancer J Clin 49 33-64
[2]  
Pisani P(2004)Focus on hepatocellular carcinoma Cancer Cell 5 215-9
[3]  
Ferlay J(2004)Hepatocellular carcinoma Lancet 362 1907-17
[4]  
Bruix J(2002)Hepatocellular carcinoma: diagnosis and treatment Gastroenterology 122 1609-19
[5]  
Boix L(2004)Hepatocellular carcinoma: recent trends in the United States Gastroenterology 127 S27-34
[6]  
Sala M(2002)A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades Proc Natl Acad Sci U S A 99 15584-9
[7]  
Llovet JM(1987)Epidemiology of hepatocellular carcinoma Gastroenterol Clin North Am 16 545-51
[8]  
Burroughs A(2004)Prevention of hepatocellular carcinoma N Engl J Med 351 1567-70
[9]  
Bruix J(1995)Hepatitis C and hepatocellular carcinoma Semin Liver Dis 15 64-9
[10]  
Befeler AS(1990)Hepatitis C-associated hepatocellular carcinoma Hepatology 12 589-91
12345678910